New Key Statistics Module, Z-Score and F-Score
SZSE:300181 Key Ratios
Market Cap ¥ M | 12,042.82 |
Enterprise Value ¥ M | 11,662.29 |
P/E(ttm) | 23.11 |
PE Ratio without NRI | 22.59 |
Forward PE Ratio | 17.91 |
Price/Book | 4.63 |
Price/Sales | 4.68 |
Price/Free Cash Flow | 102.80 |
Price/Owner Earnings | 29.55 |
Payout Ratio % | 0.59 |
Revenue (TTM) ¥ M | 2,522.00 |
EPS (TTM) ¥ | 0.74 |
Beneish M-Score | -1.71 |
10-y EBITDA Growth Rate % | 11.40 |
5-y EBITDA Growth Rate % | 47.00 |
y-y EBITDA Growth Rate % | 40.10 |
EV-to-EBIT | 19.01 |
EV-to-EBITDA | 19.01 |
PEG | 0.48 |
Shares Outstanding M | 701.39 |
Net Margin (%) | 20.52 |
Operating Margin % | 24.55 |
Pre-tax Margin (%) | 23.99 |
Quick Ratio | 1.52 |
Current Ratio | 1.93 |
ROA % (ttm) | 13.76 |
ROE % (ttm) | 19.11 |
ROIC % (ttm) | 25.64 |
Dividend Yield % | 2.62 |
Altman Z-Score | 7.32 |
SZSE:300181 Number of Guru Trades
SZSE:300181 Volume of Guru Trades
Gurus Latest Trades with SZSE:300181
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:300181 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Zhejiang Jolly Pharmaceutical Co Ltd Insider Transactions
No Available Data